ARCHIVES

Cancer Policy; Cost Containment Impedes Research, Cancer Panel Finds

This article is from The Cancer Letter archive.

Vol. 23 No. 40 | October 17, 1997

Download PDF Visit The Full Archive

Related Articles

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

NIH Workshop On Animal Care Planned

May 4, 1990

In Brief: Holleb Named Memorial Distinguished Alumnus; Hankey Appointed DCPC Statistics Branch Chief

September 1, 1989

Alternating Mammography, MRI Tested For High-Risk Women

January 30, 2009

In Aftermath of NEJM Article, Critic Bailar Declares The Defeat Of Cancer Treatment

June 6, 1997

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997